131 related articles for article (PubMed ID: 29749251)
21. Efficacy and tolerability of prucalopride in patients with constipation due to spinal cord injury.
Krogh K; Jensen MB; Gandrup P; Laurberg S; Nilsson J; Kerstens R; De Pauw M
Scand J Gastroenterol; 2002 Apr; 37(4):431-6. PubMed ID: 11989834
[TBL] [Abstract][Full Text] [Related]
22. [New treatment option for women with chronic constipation - prucalopride stimulates the disturbed gut motility again].
Z Gastroenterol; 2011 Jan; 49(1):e1-2. PubMed ID: 21243595
[No Abstract] [Full Text] [Related]
23. Response to letter: Balancing risks and benefits of prucalopride for the treatment of chronic constipation in Asians.
Ke M; Zou D; Yuan Y; Li Y; Lin L; Hao J; Hou X; Kim HJ
Neurogastroenterol Motil; 2013 Jan; 25(1):90-1. PubMed ID: 23279730
[No Abstract] [Full Text] [Related]
24. Motility: prucalopride for chronic constipation.
Bassotti G; Villanacci V
Nat Rev Gastroenterol Hepatol; 2009 Jun; 6(6):324-5. PubMed ID: 19494821
[No Abstract] [Full Text] [Related]
25. Prucalopride for the treatment of constipation: a view from 2015 and beyond.
Bassotti G; Usai Satta P; Bellini M
Expert Rev Gastroenterol Hepatol; 2019 Mar; 13(3):257-262. PubMed ID: 30791758
[TBL] [Abstract][Full Text] [Related]
26. The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study.
Every-Palmer S; Ellis PM; Nowitz M; Stanley J; Grant E; Huthwaite M; Dunn H
CNS Drugs; 2017 Jan; 31(1):75-85. PubMed ID: 27826741
[TBL] [Abstract][Full Text] [Related]
27. Lubiprostone for treatment-resistant constipation associated with clozapine use.
Meyer JM; Cummings MA
Acta Psychiatr Scand; 2014 Jul; 130(1):71-2. PubMed ID: 24912951
[No Abstract] [Full Text] [Related]
28. [Treatment of severe chronic constipation: differential roles of conventional laxatives and the prucalopride prokinetic].
Layer P; Dathe K; Dignass A; Faiss S; Galle P; Lerch MM; Malfertheiner P; Wehrmann T; Zeuzem S
Z Gastroenterol; 2011 Aug; 49(8):969-70. PubMed ID: 21796580
[No Abstract] [Full Text] [Related]
29. The use of prucalopride in real life for the treatment of constipation subtypes: ups and downs.
Bassotti G; Bellini M
Tech Coloproctol; 2013 Oct; 17(5):475-6. PubMed ID: 23703576
[No Abstract] [Full Text] [Related]
30. A randomized, double-blind, placebo-controlled trial to evaluate the efficacy, safety, and tolerability of long-term treatment with prucalopride.
Piessevaux H; Corazziari E; Rey E; Simren M; Wiechowska-Kozlowska A; Kerstens R; Cools M; Barrett K; Levine A
Neurogastroenterol Motil; 2015 Jun; 27(6):805-15. PubMed ID: 25808103
[TBL] [Abstract][Full Text] [Related]
31. Clinical trial: the efficacy of open-label prucalopride treatment in patients with chronic constipation - follow-up of patients from the pivotal studies.
Camilleri M; Van Outryve MJ; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Aliment Pharmacol Ther; 2010 Nov; 32(9):1113-23. PubMed ID: 21039673
[TBL] [Abstract][Full Text] [Related]
32. Oral prucalopride in children with functional constipation.
Winter HS; Di Lorenzo C; Benninga MA; Gilger MA; Kearns GL; Hyman PE; Vandeplassche L; Ausma J; Hoppenbrouwers M
J Pediatr Gastroenterol Nutr; 2013 Aug; 57(2):197-203. PubMed ID: 23535761
[TBL] [Abstract][Full Text] [Related]
33. Psychometric performance and clinical meaningfulness of the Patient Assessment of Constipation-Quality of Life questionnaire in prucalopride (RESOLOR) trials for chronic constipation.
Dubois D; Gilet H; Viala-Danten M; Tack J
Neurogastroenterol Motil; 2010 Feb; 22(2):e54-63. PubMed ID: 19761492
[TBL] [Abstract][Full Text] [Related]
34. Role of prucalopride in treatment of chronic constipation and recurrent functional obstruction in a patient with steinert myotonic dystrophy.
Giglio MC; Luglio G; Tarquini R; Cerbone D; Bucci P; Bucci L
J Clin Gastroenterol; 2015 Jan; 49(1):85-6. PubMed ID: 24804990
[No Abstract] [Full Text] [Related]
35. Effect of prucalopride on intestinal gas tolerance in patients with functional bowel disorders and constipation.
Malagelada C; Nieto A; Mendez S; Accarino A; Santos J; Malagelada JR; Azpiroz F
J Gastroenterol Hepatol; 2017 Aug; 32(8):1457-1462. PubMed ID: 28090679
[TBL] [Abstract][Full Text] [Related]
36. Prucalopride, a systemic enterokinetic, for the treatment of constipation.
Emmanuel AV; Roy AJ; Nicholls TJ; Kamm MA
Aliment Pharmacol Ther; 2002 Jul; 16(7):1347-56. PubMed ID: 12144586
[TBL] [Abstract][Full Text] [Related]
37. Prucalopride is effective in patients with severe chronic constipation in whom laxatives fail to provide adequate relief. Results of a double-blind, placebo-controlled clinical trial.
Coremans G; Kerstens R; De Pauw M; Stevens M
Digestion; 2003; 67(1-2):82-9. PubMed ID: 12743445
[TBL] [Abstract][Full Text] [Related]
38. [Some practical questions on chronic stipsis treatment with prucalopride].
Bellacosa L; Cogliandro R; Cremon C; De Giorgio R; Barbara G; Stanghellini V
Minerva Gastroenterol Dietol; 2014 Mar; 60(1):85-99. PubMed ID: 24632771
[TBL] [Abstract][Full Text] [Related]
39. Safety assessment of prucalopride in elderly patients with constipation: a double-blind, placebo-controlled study.
Camilleri M; Beyens G; Kerstens R; Robinson P; Vandeplassche L
Neurogastroenterol Motil; 2009 Dec; 21(12):1256-e117. PubMed ID: 19751247
[TBL] [Abstract][Full Text] [Related]
40. Neurological and psychiatric adverse events with prucalopride: case report and possible mechanisms.
Carnovale C; Pellegrino P; Perrone V; Antoniazzi S; Pozzi M; Nisic A; Clementi E; Radice S
J Clin Pharm Ther; 2013 Dec; 38(6):524-5. PubMed ID: 23889005
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
